downsides of tirzepatide for Weight Loss TrimRX | Side Effects of

Clinical trial data from SURMOUNT-1 shows that musculoskeletal complaints did not occur at significantly higher rates in the tirzepatide group compared to placebo

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2

While both semaglutide and tirzepatide have a glucagon-like peptide-1 (GLP-1) agonist component, tirzepatide also acts as an agonist of the gastric inhibitory polypeptide (GIP) hormone

But as we ageor go through stress, poor sleep, hormonal shifts, or rapid weight lossNAD+ levels drop